Events
After failing to gain market share under the umbrella of Valeant Pharmaceuticals, Addyi is getting a relaunch at half the price.
As a female chief executive officer in the healthcare industry Karen Zaderej often stands out in a male-dominated industry.
In January, Berkshire Hathaway, Amazon and JP Morgan Chase announced they were creating a joint healthcare venture. Today, they announced that Atul Gawande will be the chief executive officer.
The Biotechnology Institute gave its newly launched 2018 Woman of the Year Award to Seema Kumar.
Despite an outcry over a party featuring scantily clad women at the J.P. Morgan Healthcare Conference and a subsequent about-face by its organizers, another party at a biotech conference has now assumed the mantle of infamy.
The prevalence of nonalcoholic steatohepatitis (NASH) is increasing across the globe and is expected to be the leading indication for liver transplants by 2020. Despite that, awareness of the disease is somewhat low.
Although there are no U.S. Food and Drug Administration (FDA) approvals expected for this week, there are two Adcom meetings. Advisory Committees are used by the agency to obtain independent expert advice on scientific, technical, and policy matters.
As the BIO International Convention was wrapping up in Boston, BIO and TEConomy Partners release their 2018 “Investment, Innovation and Job Creation in a Growing U.S. Bioscience Industry” report.
In a recent interview, Ron Cohen, chief executive officer of Acorda Therapeutics, indicated that if the company lost its appeals over patent lawsuits for its Ampyra for multiple sclerosis, there would not be layoffs in its sales force.
The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science industry in California.
PRESS RELEASES